AU2001284418A1 - Novel polypeptide - Google Patents

Novel polypeptide

Info

Publication number: AU2001284418A1
Authority: AU; Australia
Prior art keywords: novel polypeptide; polypeptide; novel
Prior art date: 2000-09-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001284418A

Other versions

AU2001284418B2 (en

Inventor

Hiroyuki Mio

Satoshi Nakagawa

Hisashi Narimatsu

Ayumi Natsume

Katsutoshi Sasaki

Susumu Sekine

Akira Togayachi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kyowa Kirin Co Ltd

Original Assignee

Kyowa Hakko Kirin Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-01

Filing date

2001-08-31

Publication date

2002-06-06

2001-08-31 Application filed by Kyowa Hakko Kirin Co Ltd filed Critical Kyowa Hakko Kirin Co Ltd

2001-08-31 Priority claimed from PCT/JP2001/007563 external-priority patent/WO2002018602A1/en

2002-06-06 Publication of AU2001284418A1 publication Critical patent/AU2001284418A1/en

2007-11-01 Assigned to KYOWA HAKKO KOGYO CO., LTD., NARIMATSU, HISASHI reassignment KYOWA HAKKO KOGYO CO., LTD. Request for Assignment Assignors: KYOWA HAKKO KOGYO CO., LTD.

2007-11-08 Application granted granted Critical

2007-11-08 Publication of AU2001284418B2 publication Critical patent/AU2001284418B2/en

2008-02-08 Priority to AU2008200610A priority Critical patent/AU2008200610A1/en

2009-04-09 Assigned to NARIMATSU, HISASHI, KYOWA HAKKO KIRIN CO., LTD. reassignment NARIMATSU, HISASHI Alteration of Name(s) in Register under S187 Assignors: KYOWA HAKKO KOGYO CO., LTD., NARIMATSU, HISASHI

2021-08-31 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2008200610A AU2008200610A1 (en)	2000-09-01	2008-02-08	Novel polypeptide

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2000-265430		2000-09-01
JP2000265430		2000-09-01
PCT/JP2001/007563 WO2002018602A1 (en)	2000-09-01	2001-08-31	Novel polypeptide

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2008200610A Division AU2008200610A1 (en)	2000-09-01	2008-02-08	Novel polypeptide

Publications (2)

Publication Number	Publication Date
AU2001284418A1 true AU2001284418A1 (en)	2002-06-06
AU2001284418B2 AU2001284418B2 (en)	2007-11-08

Family

ID=18752698

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU8441801A Pending AU8441801A (en)	2000-09-01	2001-08-31	Novel polypeptide
AU2001284418A Ceased AU2001284418B2 (en)	2000-09-01	2001-08-31	Novel polypeptide

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU8441801A Pending AU8441801A (en)	2000-09-01	2001-08-31	Novel polypeptide

Country Status (6)

Country	Link
US (2)	US7279310B2 (en)
EP (1)	EP1316608A4 (en)
JP (1)	JP4995398B2 (en)
AU (2)	AU8441801A (en)
CA (1)	CA2421088A1 (en)
WO (1)	WO2002018602A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE348890T1 (en) *	2001-10-26	2007-01-15	Kyowa Hakko Kogyo Kk	METHOD FOR PRODUCING BETA-1,3-N-ACETYL GLUCOSAMINE TRANSFERASE AND A SACCHARIDE COMPOSITION CONTAINING N-ACETYL GLUCOSAMINE
JP2005065687A (en) *	2003-01-23	2005-03-17	National Institute Of Advanced Industrial & Technology	beta1,3-N-ACETYL-D-GALACTOSAMINE TRANSFERASE PROTEIN, NUCLEIC ACID ENCODING THE SAME, AND METHOD FOR TESTING CANCERATION USING THE SAME
GB0513881D0 (en)	2005-07-06	2005-08-10	Btg Int Ltd	Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en)	2003-12-22	2004-01-28	King S College London	Core 2 GlcNAc-T inhibitor
US20080182801A1 (en)	2003-12-22	2008-07-31	Btg International Limited	Core 2 glcnac-t inhibitors
JP4565177B2 (en) *	2004-07-07	2010-10-20	独立行政法人産業技術総合研究所	Pharmaceutical composition comprising β1,3-N-acetylglucosaminyltransferase for regulating cell migration activity and / or cell differentiation
GB0513888D0 (en)	2005-07-06	2005-08-10	Btg Int Ltd	Core 2 GLCNAC-T Inhibitors II
GB0513883D0 (en)	2005-07-06	2005-08-10	Btg Int Ltd	Diagnosis of Atherosclerosis
BR112017000596A2 (en) *	2014-07-14	2018-01-23	Basf Se	genetically modified microorganism, use of a genetically modified microorganism, and method for preparing lacto-n-tetraose or lacto-n-neotetraose or a spindle derivative of lacto-n-tetraose or lacto-n-neotetraose
US9616114B1 (en)	2014-09-18	2017-04-11	David Gordon Bermudes	Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US11180535B1 (en)	2016-12-07	2021-11-23	David Gordon Bermudes	Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en)	2016-12-07	2021-09-28	David Gordon Bermudes	Chimeric protein toxins for expression by therapeutic bacteria
US20190219593A1 (en) *	2018-01-14	2019-07-18	Elliot Davis	Method for identifying neoantigens on cancer cells by using xenoantibodies
US11926817B2 (en)	2019-08-09	2024-03-12	Nutcracker Therapeutics, Inc.	Microfluidic apparatus and methods of use thereof
CN113999810B (en) *	2021-12-30	2022-04-26	北京赛尔富森生物科技有限公司	MRC-5 cell recovery culture solution and recovery method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3170369B2 (en) *	1992-12-16	2001-05-28	協和醗酵工業株式会社	β1,3-galactosyltransferase
US20020115839A1 (en)	2000-08-31	2002-08-22	Millennium Pharmaceuticals, Inc.	8797, a novel human galactosyltransferase and uses thereof
WO2001044479A1 (en) *	1999-12-16	2001-06-21	Zymogenetics, Inc.	Galactosyltransferase homolog, znssp8
CA2414387A1 (en)	2000-07-07	2002-01-17	Incyte Genomics, Inc.	Drug metabolizing enzymes

2001
- 2001-08-31 EP EP01963410A patent/EP1316608A4/en not_active Withdrawn
- 2001-08-31 US US10/363,145 patent/US7279310B2/en not_active Expired - Fee Related
- 2001-08-31 JP JP2002522509A patent/JP4995398B2/en not_active Expired - Fee Related
- 2001-08-31 AU AU8441801A patent/AU8441801A/en active Pending
- 2001-08-31 AU AU2001284418A patent/AU2001284418B2/en not_active Ceased
- 2001-08-31 CA CA002421088A patent/CA2421088A1/en not_active Abandoned
- 2001-08-31 WO PCT/JP2001/007563 patent/WO2002018602A1/en active Application Filing
2007
- 2007-08-13 US US11/837,804 patent/US7629150B2/en not_active Expired - Lifetime

Publication	Publication Date	Title
AU2001284418A1 (en)	2002-06-06	Novel polypeptide
AU2001281965A1 (en)	2002-01-30	Novel 6-phenylphenanthridines
AU8441801A (en)	2002-03-13	Novel polypeptide
AU5706000A (en)	2001-01-31	Useful polypeptide
AU2691500A (en)	2000-09-14	Novel polypeptide
AU1881200A (en)	2000-08-29	Novel proteins
AU4778600A (en)	2000-12-12	Novel polypeptide
AU2002239747A1 (en)	2002-06-03	Cystoskeleton-associated proteins
AU2001244863A1 (en)	2001-10-08	Apoptin-associating protein
AU2002218199A1 (en)	2002-04-08	Truncated phosphodiesterase-7 polypeptides
AU1540701A (en)	2001-06-12	Novel protein
AU2002224056A1 (en)	2002-06-03	Novel polypeptide
AU2001278975A1 (en)	2002-02-05	Alpha-conotoxin peptides
AU2001274750A1 (en)	2002-01-02	Novel beta-hydroxyamides
AU2109200A (en)	2000-08-07	Polypeptide
AU2001241044A1 (en)	2001-09-17	Mitf-associated proteins
AU6637700A (en)	2001-03-13	Tryptase-like polypeptide ztryp1
AU2001278777A1 (en)	2002-03-04	Irap-binding protein
AU2001290317A1 (en)	2002-04-22	Novel peptides
AU2001277614A1 (en)	2002-02-18	Novel proteins
AU2001234855A1 (en)	2001-08-14	Neuropeptide-like polypeptide zpep17
AU2001294911A1 (en)	2002-04-15	Carbohydrate-associated proteins
AUPQ591200A0 (en)	2000-03-23	Novel peptides
AU2002328853A1 (en)	2003-01-21	Carcinoma-related peptides
AU2001253019A1 (en)	2001-10-15	Novel proteins